Etizolam, a benzodiazepine-class of anxiolytics, is prescribed for the treatment and management of agitation or tension and anxiety. Etizolam is also prescribed as a short-term management therapy for insomnia.
The action of Etizolam is similar to action of diazepam
No information available
No information available
Etizolam can cause confusion, amnesia, visual changes, urinary incontinence or retention, drowsiness, ataxia, depression, dysarthria, loss or changes in libido, vertigo, tremor and muscle weakness.
Etizolam is contraindicated in patients with myasthenia gravis, coma, acute pulmonary insufficiency, sleep apnoea, severe hepatic disorders, acute narrow-angle glaucoma, chronic psychiatric illness, porphyria, hypotension, patients with history of alcohol or substance abuse, suicidal thoughts and impaired renal clearance disorders.
No information available
Etizolam may interact with sedatives, CNS depressant, anti-depressant, sedating anti-histamines, anti-psychotics, disulfiram, clozapine, cisapride, opioid analgesics, diazoxide, cimetidine, proton-pump inhibitors, muscle relaxants, ACE II inhibitors, alcohol, beta-blockers, anti-epileptics and sodium nitroprusside.
No information available
Short-term management of anxiety and insomnia (Adults):
Consider oral administration of Etizolam, up to 3 mg/day as divided doses or as a single dose at bedtime.
Etizolam should be taken with food, usually within 15 to 30 minutes after meals intake.
USFDA pregnancy category C. May be or may not be harmful to an unborn baby. Consult a physician if you are in gestation or planning to have a baby during Etizolam treatment.
It is not known whether Etizolam can pass through the breast milk or not. Breastfeeding mothers should avoid nursing while taking Etizolam.
No information available
No information available
No information available
No information available
No information available
You will hear from us only if the bid amount matches the minimum threshold and intended usage match our vision. You can resubmit another bid.